Three pilot studies with very small sample sizes, a Phase II trial whose results remain unpublished, and a regulatory record that reflects the FDA's own assessment that sufficient human safety data do not exist that is the complete ledger as of 2025
Article Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W., & Lipshultz, L.I
Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 agonist): thats a very complicated name for a very clever type of drug
the data from these two large, well-powered clinical trials will provide robust evidence on the cardiovascular and metabolic benefits of tirzepatide, potentially expanding the treatment options for adults with T2DM, obesity, and related cardiovascular complications [7] (Clinical Traials.gov)
Advertisements promoting treatments for erectile dysfunction seem to be everywhere
Key Takeaways An injectable weight loss medication can cost patients anywhere from $1,000 to $1,350 for a one-month supply if it is not covered by their health insurance plan